There are 3.3 million breast cancer survivors in the United States who have undergone breast implant augmentation surgery. Worldwide, more than 10 million women are living with breast implants. In recent years, many complications have been attributed to these implants.
Some women experience breast implant illness, for which symptoms may include chronic fatigue and other symptoms associated with an autoimmune disease. Other women may have implants that develop a rare type of T-cell non-Hodgkin’s lymphoma around the breast implant. As of 2019, 656 cases of this rare type of lymphoma have been reported, but the actual numbers are believed to higher. Additionally, 17 deaths have been associated with this condition. In March 2019, the United States Food and Drug Administration held a meeting specifically to address the rising concerns for breast implant associated complications.